|
Volumn 23, Issue 1, 2009, Pages 76-79
|
Chitosan glycerophosphate-based semirigid dexamethasone eluting biodegradable stent
|
Author keywords
Chitosan; Drug; Eluting; Glycerophosphate; Rabbit; Rabbit model; Sinusitis; Stent; Steroids
|
Indexed keywords
CHITOSAN DERIVATIVE;
CHITOSAN GLYCEROPHOSPHATE;
DEXAMETHASONE;
STEROID;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BIODEGRADABLE IMPLANT;
BLOOD SAMPLING;
CONTROLLED STUDY;
DEACETYLATION;
DRUG ELUTING STENT;
DRUG FORMULATION;
DRUG RELEASE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HISTOPATHOLOGY;
IN VIVO STUDY;
INFLAMMATION;
LONGEVITY;
MAXILLARY SINUS;
NONHUMAN;
NOSE MUCUS;
POSTOPERATIVE PERIOD;
RABBIT;
STRUCTURE ANALYSIS;
ABSORBABLE IMPLANTS;
ANIMALS;
BIOCOMPATIBLE MATERIALS;
CHITOSAN;
DEXAMETHASONE;
DISEASE MODELS, ANIMAL;
DRUG COMBINATIONS;
DRUG-ELUTING STENTS;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
MAXILLARY SINUSITIS;
NASAL OBSTRUCTION;
OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES;
PLIABILITY;
POSTOPERATIVE COMPLICATIONS;
PROSTHESIS DESIGN;
RABBITS;
TREATMENT OUTCOME;
|
EID: 70149102853
PISSN: 19458924
EISSN: 19458932
Source Type: Journal
DOI: 10.2500/ajra.2009.23.3268 Document Type: Article |
Times cited : (14)
|
References (9)
|